Clinical Trial Update: Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pharmacodynamic effects of sotagliflozin vs empagliflozin in type 2 diabetes patients with mild to moderate hypertension completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus | Phase 2 | Status: COMPLETED